BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 22981727)

  • 1. Prognostic significance of 18-FDG PET/CT and EUS-defined tumour characteristics in patients with oesophageal cancer.
    Chan DS; Fielding P; Roberts SA; Reid TD; Ellis-Owen R; Lewis WG
    Clin Radiol; 2013 Apr; 68(4):352-7. PubMed ID: 22981727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of novel ¹⁸F-FDG PET/CT defined tumour variables in patients with oesophageal cancer.
    Foley KG; Fielding P; Lewis WG; Karran A; Chan D; Blake P; Roberts SA
    Eur J Radiol; 2014 Jul; 83(7):1069-1073. PubMed ID: 24794862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commentary on: Prognostic significance of 18-FDG PET/CT and EUS-defined tumour characteristics in patients with oesophageal cancer.
    Chowdhury FU; Radhakrishna G; Godfrey EM
    Clin Radiol; 2013 Apr; 68(4):338-9. PubMed ID: 23164464
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic significance of endoluminal ultrasound-defined disease length and tumor volume (EDTV) for patients with the diagnosis of esophageal cancer.
    Twine CP; Roberts SA; Lewis WG; Dave BV; Rawlinson CE; Chan D; Robinson M; Crosby TD
    Surg Endosc; 2010 Apr; 24(4):870-8. PubMed ID: 19730945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
    Yoo IeR; Chung SK; Park HL; Choi WH; Kim YK; Lee KY; Wang YP
    Biomed Mater Eng; 2014; 24(6):3091-103. PubMed ID: 25227018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy.
    Cerfolio RJ; Bryant AS; Ohja B; Bartolucci AA; Eloubeidi MA
    J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1232-41. PubMed ID: 15942562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-FDG PET/CT as a potential predictor of survival in patient with oesophageal cancer: a preliminary result.
    Fathinul Fikri AS; Dharmendran R; Vikneswaran P; Nordin AJ
    Abdom Imaging; 2015 Aug; 40(6):1457-64. PubMed ID: 25576048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response monitoring of neoadjuvant therapy using CT, EUS, and FDG-PET.
    Sloof GW
    Best Pract Res Clin Gastroenterol; 2006; 20(5):941-57. PubMed ID: 16997171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.
    Swisher SG; Maish M; Erasmus JJ; Correa AM; Ajani JA; Bresalier R; Komaki R; Macapinlac H; Munden RF; Putnam JB; Rice D; Smythe WR; Vaporciyan AA; Walsh GL; Wu TT; Roth JA
    Ann Thorac Surg; 2004 Oct; 78(4):1152-60; discussion 1152-60. PubMed ID: 15464463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic tumor volume provides complementary prognostic information to EUS staging in esophageal and junctional cancer.
    Malik V; Johnston C; O'Toole D; Lucey J; O'Farrell N; Claxton Z; Reynolds JV
    Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27862622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of occult lymph node metastasis by metabolic parameters in patients with clinically N0 esophageal squamous cell carcinoma.
    Moon SH; Kim HS; Hyun SH; Choi YS; Zo JI; Shim YM; Lee KH; Kim BT; Choi JY
    J Nucl Med; 2014 May; 55(5):743-8. PubMed ID: 24700884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET/CT predicts survival in patients undergoing primary surgery for esophageal cancer.
    Lindner K; Palmes D; Senninger N; Hummel R
    Langenbecks Arch Surg; 2015 Feb; 400(2):229-35. PubMed ID: 25572665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?
    Cuellar SL; Carter BW; Macapinlac HA; Ajani JA; Komaki R; Welsh JW; Lee JH; Swisher SG; Correa AM; Erasmus JJ; Hofstetter WL
    J Thorac Oncol; 2014 Aug; 9(8):1202-6. PubMed ID: 25157774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value comparison between (18)F-FLT PET/CT and (18)F-FDG PET/CT volume-based metabolic parameters in patients with head and neck cancer.
    Hoshikawa H; Mori T; Yamamoto Y; Kishino T; Fukumura T; Samukawa Y; Mori N; Nishiyama Y
    Clin Nucl Med; 2015 Jun; 40(6):464-8. PubMed ID: 25546204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definitive chemo-radiotherapy for squamous cell carcinoma of the pharynx: impact of baseline low hemoglobin level (<12 g/dL) and post-radiation therapy F-18 FDG-PET/CT.
    Katahira-Suzuki R; Hata M; Tateishi U; Taguchi T; Takano S; Omura-Minamisawa M; Inoue T
    Ann Nucl Med; 2015 Jan; 29(1):37-45. PubMed ID: 25228378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the introduction of integrated PET-CT into the preoperative staging pathway of patients with potentially operable oesophageal carcinoma.
    Salahudeen HM; Balan A; Naik K; Mirsadraee S; Scarsbrook AF
    Clin Radiol; 2008 Jul; 63(7):765-73. PubMed ID: 18555034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic value of the metabolically active tumour volume].
    Paumier A; Marquis A; Trémolières P; Lacombe M; Capitain O; Septans AL; Peyraga G; Gustin P; Vénara A; Ménager É; Visvikis D; Couturier O; Rio E; Hatt M
    Cancer Radiother; 2016 Feb; 20(1):24-9. PubMed ID: 26762703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma.
    Hyun SH; Choi JY; Shim YM; Kim K; Lee SJ; Cho YS; Lee JY; Lee KH; Kim BT
    Ann Surg Oncol; 2010 Jan; 17(1):115-22. PubMed ID: 19826877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-staging of oesophageal and junctional carcinoma: is there still a role for EUS in patients staged N0 at PET/CT?
    Foley KG; Lewis WG; Fielding P; Karran A; Chan D; Blake P; Roberts SA
    Clin Radiol; 2014 Sep; 69(9):959-64. PubMed ID: 24916652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in Total Lesion Glycolysis Evaluated by Repeated F-18 FDG PET/CT as Prognostic Factor in Locally Advanced Esophageal Cancer Patients Treated with Preoperative Chemoradiotherapy.
    Chang S; Koo PJ; Kwak JJ; Kim SJ
    Oncology; 2016; 90(2):97-102. PubMed ID: 26771676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.